Background: is a significant contributor to a range of gastrointestinal conditions, with conventional treatment methods primarily relying on antibiotics. However, the rise of antibiotic-resistant strains has necessitated the exploration of alternative therapeutic approaches.
Objectives: To determine the antibacterial potential of probiotic bacteria ( BLRH 260 and ) and four propolis extracts against and to analyze their impacts on body weight index and histopathological changes in -challenged Wistar rats.
Methods: The inhibitory effects of probiotic bacteria ( BLRH 260 and ) and propolis extracts on the growth of were evaluated using an agar well diffusion assay. In vivo analysis involved fifty-four male Wistar rats (200 - 250 g) infected with an suspension (10 CFU/mL) and orally administered propolis or probiotics (10 CFU/mL) via gavage for 21 days. The effects of different treatments on body weight and histopathological changes in gastric tissue samples were assessed, and the results were statistically analyzed.
Results: The tested propolis extracts and the supernatant fluids from the mentioned probiotic strains showed significant antibacterial activity against in the agar well diffusion assay, with notable variations. In vivo, the findings demonstrated that oral administrations of propolis and probiotics, either separately or in combination, led to significant increases in body weight and amelioration of histopathological changes in gastric tissue samples, particularly in terms of erosion depth, hemorrhagic inflammation, and apoptosis in the infected animals. Histopathological differences between antibiotic-treated animals and those receiving other treatments were observed, with significant differences.
Conclusions: The results of this study underscore the potential therapeutic benefits of propolis and probiotics in addressing -induced gastropathy. Additional research is necessary to clarify the mechanisms involved and to refine dosage and treatment protocols for optimal effectiveness.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892748 | PMC |
http://dx.doi.org/10.5812/ijpr-148158 | DOI Listing |
Iran J Pharm Res
December 2024
Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background: is a significant contributor to a range of gastrointestinal conditions, with conventional treatment methods primarily relying on antibiotics. However, the rise of antibiotic-resistant strains has necessitated the exploration of alternative therapeutic approaches.
Objectives: To determine the antibacterial potential of probiotic bacteria ( BLRH 260 and ) and four propolis extracts against and to analyze their impacts on body weight index and histopathological changes in -challenged Wistar rats.
J Pharm Bioallied Sci
December 2024
Department of Pedodontics, College of Dental Sciences, Davangere, Karnataka, India.
Aim: Aim of the study is to evaluate microleakage of conventional GIC and addition of 1% ethanolic extract of propolis to conventional GIC.
Methodology: A study was conducted between two groups. Group A was the conventional GIC group (control) and Group B was treated with GIC incorporated with 1% ethanolic extract of propolis (experimental).
Prev Nutr Food Sci
February 2025
Department of Food Engineering, Faculty of Agriculture, Tekirdag Namik Kemal University, Tekirdag 59030, Türkiye.
This study aimed to investigate whether L-lactic acid (LA), as a better solvent than ethanol (EtOH), enhances the bioaccessibility of phenolic compounds in red and green Brazilian propolis and to evaluate their potential anticancer effects . gastrointestinal digestion was performed by sequentially subjecting propolis extracts to buccal, gastric, and intestinal digestion phases, and samples were collected at each stage for analysis. The total phenolic content (TPC) was determined using the Folin-Ciocalteu reagent with gallic acid as a standard.
View Article and Find Full Text PDFPhytomedicine
March 2025
São Paulo State University (UNESP), Institute of Biosciences, Campus Botucatu, 18618-691, Brazil. Electronic address:
Background: Propolis has been traditionally used to treat inflammatory and infectious diseases, and it is still used and researched worldwide. Methicillin-resistant Staphylococcus aureus (MRSA) may cause invasive infections and propolis anti-MRSA activity has been analyzed.
Purpose: A standardized red propolis extract (SRPE), its benzophenones-rich fraction (BRF), and isolated benzophenones (guttiferone E - GUT E, and oblongifolin B - OBL B) were assayed for their antibacterial and immunomodulatory action.
Biosci Biotechnol Biochem
March 2025
Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
Propolis is a resinous substance collected by honeybees from the buds and bark of certain trees and plants and is stored in hives. Our previous studies have shown that the major components of propolis from Jeju Island, Korea, are chalcone and coumarin analogs. In this study, we aimed to elucidate the functional properties of propolis obtained from Jeju Island.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!